Learman Lee A, Summitt Robert L, Varner R Edward, McNeeley S Gene, Goodman-Gruen Deborah, Richter Holly E, Lin Feng, Showstack Jonathan, Ireland Christine C, Vittinghoff Eric, Hulley Stephen B, Washington A Eugene
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94110, USA.
Obstet Gynecol. 2003 Sep;102(3):453-62. doi: 10.1016/s0029-7844(03)00664-1.
To compare surgical complications and clinical outcomes after total versus supracervical abdominal hysterectomy for control of abnormal uterine bleeding, symptomatic uterine leiomyomata, or both.
We conducted a randomized intervention trial in four US clinical centers among 135 patients who had abdominal hysterectomy for symptomatic uterine leiomyomata, abnormal uterine bleeding refractory to hormonal treatment, or both. Patients were randomly assigned to receive a total or supracervical hysterectomy performed using the surgeon's customary technique. Using an intention-to-treat approach, we compared surgical complications and clinical outcomes for 2 years after randomization.
Sixty-eight participants were assigned to supracervical hysterectomy (SCH) and 67 to total abdominal hysterectomy (TAH). Hysterectomy by either technique led to statistically significant reductions in most symptoms, including pelvic pain or pressure, back pain, urinary incontinence, and voiding dysfunction. Patients randomly assigned to (SCH) tended to have more hospital readmissions than those randomized to TAH, but this difference was not statistically significant. There were no statistically significant differences in the rate of complications, degree of symptom improvement, or activity limitation. Participants weighing more than 100 kg at study entry were twice as likely to be readmitted to the hospital during the 2-year follow-up period (relative risk [RR] 2.18, 95% confidence interval [CI] 1.06, 4.48, P=.034).
We found no statistically significant differences between (SCH) and TAH in surgical complications and clinical outcomes during 2 years of follow-up.
比较全子宫切除术与次全子宫切除术治疗异常子宫出血、有症状的子宫肌瘤或两者兼有的手术并发症及临床结局。
我们在美国四个临床中心对135例行腹部子宫切除术治疗有症状的子宫肌瘤、激素治疗无效的异常子宫出血或两者兼有的患者进行了一项随机干预试验。患者被随机分配接受使用外科医生惯用技术进行的全子宫切除术或次全子宫切除术。采用意向性分析方法,我们比较了随机分组后2年的手术并发症及临床结局。
68名参与者被分配接受次全子宫切除术(SCH),67名接受全子宫切除术(TAH)。两种技术进行的子宫切除术在大多数症状方面均导致有统计学意义的改善,包括盆腔疼痛或坠胀感、背痛、尿失禁和排尿功能障碍。随机分配接受SCH的患者比接受TAH的患者更易再次入院,但这种差异无统计学意义。并发症发生率、症状改善程度或活动受限方面无统计学显著差异。研究入组时体重超过100 kg的参与者在2年随访期间再次入院的可能性是其他人的两倍(相对风险[RR] 2.18,95%置信区间[CI] 1.06,4.48,P = 0.034)。
我们发现随访2年期间,SCH和TAH在手术并发症及临床结局方面无统计学显著差异。